ner T-cell antigen receptor (TCR)-proximal signaling (reviewed in Ref. 1) . TCR triggering stimulates phosphorylation by Lck of the immunoreceptor tyrosine-based activation motifs (ITAMs) present in the signal transducing subunits (, and CD3 ␥, ␦, and ⑀) of the TCR complex (2, 3) . Phosphorylated ITAMs become then competent to bind the cytoplasmic ZAP-70 kinase via its two tandemly arranged SH2 domains (2, 4, 5) . By this mechanism, ZAP-70 is recruited to the stimulated TCRs and becomes itself phosphorylated on tyrosine, as a result of autophosphorylation (6) and transphosphorylation catalyzed by Lck (2, 7, 8) . The latter event, which implicates phosphorylation of Tyr 493 in the activation loop of the catalytic domain, is required for augmenting ZAP-70 catalytic activity (7, 9) with consequent phosphorylation of its substrates and propagation of the signaling cascade (7, 10) . Besides the direct regulation of its kinase activity, tyrosine phosphorylation of ZAP-70 appears to have additional roles such as providing binding sites for SH2 or phosphotyrosine-binding domain-containing enzymes or adapter proteins that may act as downstream effectors and/or regulators of ZAP-70 activity (6, (11) (12) (13) (14) (15) .
Recent studies in our laboratory have shown that Tyr 319 , in the linker region between the two tandem SH2 domains and the kinase domain (interdomain B; see Fig. 1 ) of ZAP-70, is a TCR-induced phosphorylation site and has an essential positive role in the regulation of the kinase (16) . Indeed, mutation of Tyr 319 to phenylalanine, although not affecting the basal kinase activity, strongly reduced the activation-induced tyrosine phosphorylation of ZAP-70 and the up-regulation of its catalytic activity following TCR stimulation. Consistently, overexpression of the mutant Y319F in T-cells severely reduced the phosphorylation of ZAP-70 substrates (SLP-76 and LAT) and the TCR-dependent activation of NFAT and interleukin-2 production (16) .
We and others have previously demonstrated that after TCR stimulation, Lck binds to ZAP-70 via its SH2 domain (LckSH2), raising the possibility that this association is required for ZAP-70 activation by Lck (11, 17, 18) . Consistently, expression in an Lck-deficient cell line of an SH2 point mutant of Lck was unable to restore the TCR-mediated activation, a defect that correlated with the lack of Lck-ZAP-70 interaction and the dramatic reduction of ZAP-70 tyrosine phosphorylation (18) .
The facts that mutation of either Tyr 319 or Tyr 493 leads to a dramatic decrease in ZAP-70 function (7, 16) and that ZAP-70-Lck interaction plays a critical role in TCR signaling suggested that tyrosine Tyr 319 may represent a binding site for LckSH2. In this work we provide evidence supporting this notion.
The minimal sequence critical for interaction with the SH2 domains of Src PTKs comprises the three amino acids immediately C-terminal to a phosphorylatable tyrosine residue (19) . By using a degenerated phosphopeptide library, it has been shown that the motif pYEEI is preferentially selected by the SH2 domain of members of the Src family of PTKs (19) . We built a molecular model of the motif encompassing Tyr 319 of ZAP-70 (YSDP) complexed to LckSH2 and found that despite the divergence between the Y 319 SDP and the optimal motif YEEI, the former possesses structural features compatible with its binding to LckSH2. Competition experiments of the binding between in vivo phosphorylated ZAP-70 and LckSH2 using a synthetic peptide comprising Y 319 SDP confirmed that this motif efficiently interacts with LckSH2, although less well than a YEEI-containing peptide. Moreover, we demonstrate that mutation of Tyr 319 to phenylalanine abolishes the interaction of ZAP-70 with the LckSH2, whereas mutation of the neighbor Tyr 315 , another residue phosphorylated in vivo following TCR triggering (16) , was ineffective. Based on these data, we generated a mutant of ZAP-70 in which the natural sequence encompassing Tyr 319 was changed to Y 319 EEI (ZAP-YEEI). This mutant showed a strong gain-of-function phenotype. Indeed, although its basal kinase activity and its capacity to bind to phosphorylated ITAMs were unaffected, ZAP-YEEI, expressed in Jurkat cells: (i) was hyperphosphorylated, an event that correlated with an augmented catalytic activity, and ii) induced a strong increase in NFAT activity. The gain-offunction phenotype of ZAP-YEEI was dependent on the cell surface expression of the TCR. These data are discussed in the context of a model in which the SH2-mediated binding of Lck to Tyr 319 provides an essential step in the activation of ZAP-70.
EXPERIMENTAL PROCEDURES
Antibodies-Polyclonal anti VSV-G rabbit antiserum (anti-tag) directed against an 11-amino acid synthetic peptide determinant (an additional cysteine was added to the C terminus for coupling to the carrier) derived from vesicular stomatitis virus glycoprotein (VSV-G) was generated in our laboratory using keyhole limpet hemocyanin as a carrier; anti ZAP-70 antiserum (4.06) was produced in our laboratory as already described (20) . The following mouse monoclonal Abs (mAbs) were used: 101.5.2 (anti-human TCR Vb8, IgM kindly provided by E. L. Reinherz, Dana-Farber Cancer Institute, Boston, MA); 4G10 (antiphosphotyrosine IgG2b, purchased from Upstate Biotechnology, Lake Placid, NY); clone 29 (anti ZAP-70 C terminus IgG2a, purchased from Transduction Laboratories, Lexington, KY); and P5D4 (anti VSV-G-tag IgG1; hybridoma kindly provided by T. E. Kreis, Department of Cell Biology, University of Geneva, Switzerland (21)).
Synthetic Peptides-The following synthetic peptides were purchased from Chiron Technologies, Clayton Victoria, Australia: YEEI (sequence EPQYEEIPI) and pYEEI (sequence EPQpYEEIPI) (where pY indicates a phosphotyrosine residue), derived from the hamster polyoma MT sequence (19) ; pYSDP (sequence ESPpYSDPEE), pYESP (sequence TSVpYESPYS), and pYTPE (sequence SDGpYTPEPA) encompassing residue Tyr 319 , Tyr 315 , and Tyr 292 of human ZAP-70, respectively. A peptide (phospho-ITAM) corresponding to the first ITAM motif of the human TCR-chain (residues 48 -66) plus a 4-amino acid linker at the N terminus (sequence: SGSGNQLYNELNLGRREEYDVLD) was synthesized as diphosphorylated on Tyr 51 and Tyr 62 form (by F. Baleux, Department of Organic Chemistry, Institut Pasteur, Paris, France). Phospho-ITAM was purified by reverse-phase high pressure liquid chromatography and biotinylated at the N terminus by Biotin sulfo-NHS (Pierce). The purity and the molecular mass of the peptides were confirmed by ion electrospray ionization mass spectrometry.
Cell Lines-The human leukemia Jurkat T-cell line was maintained in RPMI 1640 supplemented with 10% fetal calf serum, 10 mM Hepes, 2 mM L-glutamine, 100 units/ml penicillin, and 100 g/ml streptomycin (Life Technologies, Inc.) (complete RPMI 1640 medium). 31-13 T-cell line, a derivative of the Jurkat T-cell line, which does not express the TCR due to the lack of the TCR ␤ chain transcript (22) , was maintained in complete RPMI 1640 medium. ␤WT160 was obtained from 31-13 cells by stable transfection of the TCR ␤-chain (22) and maintained in complete RPMI 1640 medium also containing 2 g/liter of G-418 (Life Technologies, Inc.). Jurkat stable transfectants expressing ZAP-70-WT (clone 15.8), ZAP-70-Y319F (clones 1.40 and 1.60), and ZAP-70Y315F (clones 2.21/14 and 2.21/2) were previously described in Ref. 16 .
Constructions and Plasmids-NFAT-luciferase (NFAT-luc) reporter construct (10) was kindly provided by C. Baldari (University of Siena, Italy). pSV-bgal vector (Promega) contained the ␤-galactosidase gene driven by the SV40 promoter/enhancer. The ZAP-WT construct, bearing a C-terminal 11-amino acid epitope VSV-G-tag was described previously (10 Model Building-The structure of the SH2 domain of Lck with the phosphotyrosine in its binding pocket was derived from the crystallographic atomic coordinates of the LckSH2-pYEEI peptide complex (25) (Protein Data Bank code 1LCJ). The CHARMM academic program was used to built sequentially the amino acids (SDP) ab initio. For each structure of the previous step (the crystallographic one for the first step, i.e. the pY residue) the next amino acid was appended either in its standard ␤-sheet conformation or rotated every 30 degrees along its phi angle. Then the system was subjected to 10 ps of molecular dynamics at 3000 K for each rotamer. The conformations were saved every 0.1 ps, minimized, and grouped into clusters. The lowest energy structure of each cluster (about a dozen) was kept to initiate the next step of the building. The resulting structure was both the one with the lowest energy and the one belonging to the largest cluster. We used a sigmoidal dielectric constant to mimic the effect of the solvent while enabling fast evaluations of the energy minimizations or molecular dynamics and therefore a wide sampling.
Cell Transfection, Activation, and NFAT Luciferase Activity AssaysTransient transfections of Jurkat cells were performed by electroporation (260 V, 960 microfarads) as already described (10) with the indicated doses of pSR␣-puro vector without insert (empty vector) or containing ZAP-WT or ZAP-Y 319 EEI, 10 g of NFAT-luc plasmid, and 30 g of pSV-bgal plasmid. The total amount of plasmidic DNA was equalized with the empty pSR␣-puro vector. Transfected cells were cultured for 24 h, and then 10 5 cells were seeded in 100 ml of growth medium into U-bottomed 96-well plates. Cells were left unstimulated or stimulated at 37°C for 8 h with 101.5.2 anti-TCR mAb (precoated to wells at 1:1000 dilution of ascites) or with phorbol 12-myristate 13-acetate (50 ng/ml) (Sigma) and calcium ionophore A23187 (2 g/ml) (Sigma). ␤-Galactosidase and luciferase assays were performed by using the specific assay systems (Promega). Luciferase activity was determined in triplicate samples using an automated luminometer (Lumat LB 9501, Berthold, Wildbad, Germany) and expressed as a percentage of maximal response (percentage of phorbol 12-myristate 13-acetate/ionophore).
Phosphopeptide Analysis-The GST-(⌬SH2)ZAP-70 fusion proteins (WT and mutant) were autophosphorylated for 30 min at room temperature in 1 mM Tris, pH 7.4, 7.5 mM NaCl, 25 mM Hepes, 10 mM MnCl 2 , 0.05% Nonidet P-40 and in the presence of 10 Ci of [␥-
32 P]ATP. Reaction products were separated by SDS-PAGE and transferred onto nitrocellulose membranes.
32 P-Labeled bands were excised and incubated with 0.5 M CNBr (Fluka) in 70% formic acid for 1.5 h at room temperature (26) . Cleavage products were separated on Tris-Tricine SDS-PAGE as described (16, 27) . Gels were dried and exposed for autoradiography. For LckSH2 binding, CNBr cleavage products were resuspended in 1% SDS, 20 mM Tris, pH 7.4, 150 mM NaCl and then diluted 10-fold in 1% Nonidet P-40, 20 mM Tris, pH 7.4, 150 mM NaCl and incubated for 1 h at 4°C in the presence of MBP-LckSH2 Sepharose beads (11) . Beads were washed, and bound peptides were analyzed in Tris-Tricine SDS-PAGE, as described above.
Immunoprecipitation and SH2 Binding Assays-Jurkat T-cells transfectants were stimulated with pervanadate 5 min at 37°C or left unstimulated and lysed in 1% Nonidet P-40-containing buffer (10) . Immunoprecipitation, SH2 binding assays, immunoblotting, and detection of proteins by enhanced chemiluminescence (Amersham Pharmacia Biotech) were performed as described previously (10, 11) .
Phosphopeptide Binding Assays-For phosphopeptide competition binding assays, 5 ϫ 10 7 Jurkat cells were activated 5 min at 37°C with pervanadate and lysed in 1% Nonidet P-40 containing buffer (10) . One-tenth of the lysate was incubated on 10 ml of MBP-LckSH2 beads 1 h at 4°C in 45 l of 20 mM Tris, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, containing increasing concentrations of competitor phosphopeptide (11). LckSH2-bound protein were separated on SDS-PAGE and subjected to immunoblotting with an anti-ZAP-70 mAb (clone 29). Phospho-ITAM peptide binding was performed as described previously (20) .
In Vitro Kinase Assays-Transfected cells were lysed in 1% Nonidet P-40-containing buffer and expressed ZAP-70-WT or mutant was immunoprecipitated by anti VSV-G tag antiserum. Anti VSV-G tag immunoprecipitates were washed four times in Nonidet P-40 containing buffer and twice with kinase buffer (25 mM MES buffer, pH 6.5, 10 mM MnCl 2 ) and then incubated at room temperature for 5 min in 25 l of kinase buffer containing 0.5 M of [␥-
32 P]ATP (specific radioactivity, 20 mCi/mmol) and 20 ng of GST-Band III. The reaction was stopped by adding an equal volume of 2ϫ Laemmli sample buffer containing 200 mM dithiothreitol, 10 mM EDTA and boiling for 5 min. Samples were resolved by SDS-PAGE and transferred onto polyvinylidene difluoride membranes (Millipore). Membranes were treated with KOH 1 M for 1 h at 55°C and dried before autoradiography. An aliquot of each sample was used to quantify the amount of immunoprecipitated proteins, by immunoblotting with an anti ZAP-70 antiserum (4.06) and probing the Western blots with 125 I-labeled protein A. In both the kinase assay and the protein quantitation, radiolabeled bands corresponding to ZAP-70 (ZAP-70 WT and ZAP-70-Y 319 EEI) or the phosphorylated GST-Band III were visualized by autoradiography and quantitated by using Image Quant software after scanning in a PhosphorImager (Amersham Pharmacia Biotech).
RESULTS

YSDP Motif from the Interdomain B of ZAP-70 Is Able to
Bind LckSH2-The similar phenotype displayed by Y319F and Y493F ZAP-70 mutants (7, 16) together with the critical role of the SH2-mediated interaction between ZAP-70 and Lck in TCR signaling (11, 18) , suggested that Tyr 319 could be a binding site for the LckSH2. However, this residue is located in the motif YSDP ( Fig. 1) , which considerably diverges from YEEI, an optimal binding sequence for the SH2 domain of Src PTKs (19) . Thus, we used molecular modeling to address the question of whether the sequence YSDP could fit the LckSH2-binding site. The molecular modeling was based on the crystallographic atomic coordinates of the LckSH2-pYEEI peptide complex (25) . To avoid any bias, this model was built with no other information than the structure of the LckSH2 domain, with the pY residue lodged in its binding pocket (for further details see "Experimental Procedures"). As shown in Fig. 2 , the structural resemblance between the built pYSDP peptide (yellow in the figure) and the pYEEI (gray in the figure) was striking. The backbone of the two peptides almost superimposed, with a root mean square deviation for the C␣ of residues Yϩ1, Yϩ2, and Yϩ3 of 0.48 Å. This was also the case for the side chains of the proline residue ϩ3 of the YSDP peptide and the side chain of the isoleucine ϩ3 of the YEEI peptide, fitting on the Yϩ3 binding pocket (root mean square deviation for the C␤ and C␥ of the side chains of the Yϩ3 proline and isoleucine residues of 0.47 Å). Moreover, as shown in Fig. 2B , the aspartate side chain of the residue Yϩ2 of the YSDP peptide would be in a favorable position for interacting with the arginine R␤DЈ1 of the LckSH2. The data from this molecular modeling show that the binding pocket of LckSH2 can accommodate the YSDP motif, suggesting that no structural constraints would impede this intermolecular interaction.
To confirm the prediction arising from the molecular modeling, i.e. that Y 319 SDP could bind to LckSH2, we initially carried out a series of competition experiments, employing a previously described binding assay (11) . Lysates from activated Jurkat cells were incubated with LckSH2 beads in the presence of different concentrations of a pYSDP-containing nonapeptide. The binding capacity of this peptide was compared relatively to three nonamer phosphopeptides containing the optimal motif (pYEEI) or encompassing Tyr 292 (pYTPE) or Tyr 315 (pYESP) of ZAP-70, two residues that lie in the interdomain B of the kinase and are phosphorylated in vivo (8, 16 ). An unphosphorylated version of the nonamer peptide containing the YEEI motif was used as a control. LckSH2-bound proteins were separated by SDS-PAGE and analyzed by anti-ZAP-70 immunoblot. Only ZAP-70 from activated cells specifically bound to LckSH2 beads (Fig. 3C and data not shown) . Fig. 3A shows that the phosphopeptide pYEEI was able to effectively compete for the binding of ZAP-70 to LckSH2, even at the lowest concentration tested (compare 11 M of pYEEI peptide with 300 M of the YEEI control peptide). The signal had almost disappeared at 300 M pYEEI. Phosphopeptide pY 319 SDP was also able to compete for ZAP-70 binding, although less effectively than pYEEI. Indeed, repeated competition experiments allowed us to estimate that pY 319 SDP bound to LckSH2 with about ϳ10-fold lower affinity than the optimal phosphopeptide pYEEI, even though this difference in affinity appears to be less pronounced in the experiment of Fig. 3A . In analogous experiments, the pY 315 ESP-containing phosphopeptide was a much less effective competitor than Y 319 SDP, whereas pY 292 TPE was totally ineffective in competing for the binding of ZAP-70 to LckSH2 (Fig. 3A) . These findings demonstrate that although less efficient than the optimal sequence pYEEI, the Tyr(P) 319 (16) . All the constructs were tagged at the C terminus with a VSV-G-derived peptide (21) . The 15.8 cell line expressing ZAP-WT was used as a control. The cell lines 1.40 and 1.60 expressed ZAP-Y319F, whereas the cell lines 2.21/14 and 2.21/2 expressed the ZAP-Y315F mutant. The relative expression levels of ZAP-70 tagged constructs in these cell lines, which have been previously characterized (16) , are shown in Fig. 3B . Because previous studies have indicated that the ZAP-Y319F mutant is considerably less phosphorylated than ZAP-WT (16), Jurkat cell transfectants were activated by pervanadate, a stratagem that enables to bypass these differences. It is reasonable to assume that under these experimental conditions, homogeneous tyrosine phosphorylation of all ZAP-70 constructs was attained, with the obvious 
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exception of the mutated tyrosines in ZAP-Y315F and ZAP-Y319F. Lysates were incubated with LckSH2 coupled to beads, and bound proteins were analyzed by SDS-PAGE and anti-tag immunoblotting. Fig. 3C shows that despite comparable levels of phosphorylated ZAP-70 constructs present in the lysates from stimulated cells (upper panel), only ZAP-WT and ZAP-Y315F were able to bind to LckSH2 (lower panel), whereas binding was completely abolished in Y319F-expressing clones. The slightly higher amount of ZAP-Y315F bound to LckSH2 compared with ZAP-WT is explained by the higher expression level of the mutant in the 2.21/14 and 2.21/2 cell lines (Fig. 3B ). These results demonstrate that Tyr 319 is required for the binding of ZAP-70 to LckSH2 and confirmed previous findings by Wu et al. (28) showing that Tyr 315 of ZAP-70 is not involved in this interaction. 319 Binds Specifically to LckSH2-The results shown in Fig. 3C did not allow exclusion of the possibility that the inability of the mutant ZAP-Y319F to bind the Lck SH2 was due to an indirect effect, e.g. inhibition of the phosphorylation of another tyrosine residue (16) . To address 
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the direct involvement of Tyr 319 in the binding of the LckSH2, we made use of a GST-ZAP-70 fusion protein, which lacks the SH2 domains but contains the interdomain B and the catalytic domain (residues 255-619) of human ZAP-70 sequence (GST-(⌬SH2)ZAP). Three different fusion proteins were used: the wild-type construct (GST-(⌬SH2)ZAP-WT) and the two mutants where Tyr 315 or Tyr 319 were replaced by phenylalanine (GST-(⌬SH2)ZAP-Y315F and GST-(⌬SH2)ZAP-Y319F, respectively). When GST-(⌬SH2)ZAP-WT was autophosphorylated in vitro in the presence of [␥-
32 P]ATP and chemically cleaved with CNBr, two major tyrosine phosphorylated peptides could be detected in Tris-Tricine SDS-PAGE slabs (indicated as I and II in Fig. 3D (16) . Indeed, as we have previously shown, in the GST-(⌬SH2)ZAP-WT construct, essentially Tyr 315 and Tyr 319 are phosphorylated (16) . Comparison of the CNBr phosphopeptide pattern of autophosphorylated GST-(⌬SH2)ZAP-Y315F and GST-(⌬SH2)ZAP-Y319F to the GST-(⌬SH2)ZAP-WT showed no qualitative differences (Fig. 3D, left panel) , thus indicating that neither mutation grossly altered protein autophosphorylation in vitro (note that an equal amount of radioactivity was loaded in each lane). However, when CNBr-cleaved proteins were incubated with LckSH2, binding could be detected for peptides from the GST-(⌬SH2)ZAP-WT and GST-(⌬SH2)ZAP-Y315F constructs, whereas virtually no peptide from the CNBr-cleaved GST-(⌬SH2)ZAP-Y319F was able to bind to LckSH2 (Fig. 3D, (19) . Consistent with this, the affinity of the pYEEI for LckSH2 is higher than that of pYSDP (Fig. 3A) . Therefore, we speculated that the introduction of a YEEI sequence in place of Y 319 SDP in ZAP-70 would lead to a stronger interaction of Lck with ZAP-70 and consequently to a gain-of-function. Thus, a ZAP-70 mutant Equal amounts of radioactivity were loaded in each lane. Another aliquot was subjected to LckSH2 binding, and bound peptides were subsequently analyzed by Tris-Tricine SDS-PAGE (right panel). Gels were dried and exposed for autoradiography.
(ZAP-YEEI) was generated in which the sequence Y 319 SDP was changed to Y 319 EEI (Fig. 1) . C-terminally tagged ZAP-YEEI or ZAP-WT constructs were transiently expressed in Jurkat cells together with an NFAT-luc reporter plasmid that was used as a read-out for cellular activation (10, 29) . As previously demonstrated (10), overexpression of ZAP-WT in unstimulated Jurkat cells induced a moderate increase in NFAT activity (Fig.  4A) . The activating effect of ZAP-WT overexpression in the absence of the TCR cross-linking is likely to depend on ZAP-70 being recruited to the phosphorylated ITAMs (see also below). Indeed, we and others have previously shown that overexpression of tandem SH2 domain of ZAP-70 leads per se to an increase of ITAM tyrosine phosphorylation, as a consequence of protecting them from dephosphorylation by protein-tyrosine phosphatases (10, 30, 31) . Thus, when overexpressed, ZAP-70 generates its own binding sites on the ITAMs. In agreement with the initial hypothesis, expression of ZAP-YEEI at levels similar to ZAP-WT induced a much higher NFAT activity in unstimulated Jurkat cells (Fig. 4A) . When the cells were stimulated by TCR cross-linking, we found that transfection of both ZAP-WT and ZAP-YEEI induced an increase in NFAT transcriptional activity compared with cells transfected with the empty vector, with ZAP-YEEI being more efficient than ZAP-WT (Fig. 4A) . Generalized effects on gene expression by ZAP-YEEI can be excluded because no enhancement of the expression levels of a ␤-galactosidase gene driven by a constitutive promoter was noticed in transfected cells (not shown). The activating effect of ZAP-YEEI in unstimulated cells was dose-dependent, reaching a plateau at 10 g of transfected DNA (Fig. 4B) , and was 5-20-fold higher than that observed with ZAP-WT.
These data demonstrate that changing the sequence Y The gain-of-function phenotype of ZAP-YEEI was not observed in T-cells lacking surface expression TCR-CD3 complex. Indeed, when ZAP-WT or ZAP-YEEI was expressed in 31-13 cells, a TCR-negative cell line derived from Jurkat (22) , no NFAT activation was observed (Fig. 4C) . On the other hand, when expressed in ␤WT160, a 31-13 derivative in which TCR expression was rescued by stably transfecting the TCR-␤ chain (22) , ZAP-YEEI led to NFAT activation in absence of TCR stimulation (Fig. 4C) , as previously shown for Jurkat cells (Fig.  4, A and B) . A moderate effect of NFAT activation was also observed when ZAP-WT was expressed in ␤WT160 (Fig. 4C) . These experiments demonstrated that to fulfill its increased signal transducing capacity, ZAP-YEEI required the expression of the ITAMs at the cell membrane. Thus, as observed in TCR-negative 31-13 cells, overexpression of ZAP-YEEI was not sufficient to exert its effect but required recruitment of the mutant kinase to the TCR, where it was able to activate downstream signaling pathways.
ZAP-YEEI Shows an Increased Tyrosine Phosphorylation and Kinase Activity-As the Y
319 SDP to Y 319 EEI mutation is expected to result in an increased affinity of the SH2-mediated 
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interaction between Lck and ZAP-70, the gain-of-function phenotype of ZAP-YEEI should be mediated by a more efficient phosphorylation/activation of the mutant by Lck. Indeed, when ZAP-WT and ZAP-YEEI were expressed in unstimulated Jurkat cells, immunoprecipitation experiments followed by antiphosphotyrosine immunoblotting revealed that the phosphorylation level of ZAP-YEEI was considerably higher than that of ZAP-WT (Fig. 5A ). Such an increased phosphorylation level of ZAP-YEEI did correlate with an augmented kinase activity. As shown in Fig. 5B , when anti-tag immunoprecipitates from transiently transfected Jurkat cells were subjected to an in vitro kinase assay, using a GST-Band III fusion protein as an exogenous substrate, ZAP-YEEI displayed a kinase activity significantly higher compared with ZAP-WT. Indeed, after normalization for the amount of immunoprecipitated protein, the catalytic activity of ZAP-YEEI was found to be 3.8 Ϯ 1.0-fold (mean Ϯ S.D., n ϭ 4) higher than that of ZAP-WT. Under the conditions employed, we did not see phosphorylated bands at 55-60 kDa that might correspond to autophosphorylated Lck coprecipitating with ZAP-70 or ZAP-YEEI. This suggests that the amount of Lck and/or its kinase activity was negligible and did not contribute significantly to GST-band III phosphorylation.
Consistent with the lack of gain-of-function of ZAP-YEEI in TCR-negative 31-13 cells (Fig. 4C) , neither ZAP-WT nor ZAP-YEEI were detectably phosphorylated when expressed in these cells (Fig. 5A) . Moreover, the kinase activity of ZAP-YEEI in TCR-negative 31-13 cells was found to be comparable with that of ZAP-WT (Fig. 5B) . Indeed, the ratio of ZAP-YEEI to ZAP-WT kinase activity in these cells was 0.82 Ϯ 0.28 (mean Ϯ S.D., n ϭ 4). These results formally demonstrate that the Y 319 EEI mutation did not affect the basal kinase activity of ZAP-70, thus ruling out the possibility that increased catalytic activity of ZAP-YEEI was due to a structural alteration of the molecule. These findings also indicate that the hyperphosphorylation and the increased kinase activity of ZAP-YEEI were dependent on the presence of the ITAMs, as previously shown for the increase in NFAT activity induced by this mutant (see Fig. 4C ).
Mutation of Y 319 SDP to Y 319 EEI in ZAP-70 Does Not Affect Its Binding to Receptor ITAMs-One possible explanation for the gain-of-function phenotype of ZAP-YEEI was that the Y 319
EEI mutation leads to an increased binding to phosphorylated ITAMs in the TCR-CD3 complex. To address this question, TCR-negative 31-13 cells were transiently transfected with ZAP-WT or ZAP-YEEI, and cellular lysates were mixed with a biotinylated, doubly phosphorylated peptide encompassing the N-terminal ITAM of TCR-(phospho-ITAM). Phospho-ITAMbound proteins were precipitated by the addition of avidin beads and subjected to SDS-PAGE and immunoblotting with an anti-tag mAb. Fig. 6 shows that similar amounts of ZAP-WT and ZAP-YEEI bound to the phospho-ITAM, demonstrating that the mutation does not increase the affinity of ZAP-70 for the phosphorylated ITAMs.
Increased Binding of ZAP-YEEI to LckSH2-We finally verified that ZAP-YEEI was able to bind LckSH2 with higher efficiency compared with ZAP-WT. ZAP-YEEI and ZAP-WT constructs were transiently expressed in Jurkat cells, and cell lysates were incubated with LckSH2 beads. The precipitates were subjected to SDS-PAGE and immunoblotted with an antitag monoclonal antibody. Fig. 7 shows that despite similar levels of expression of ZAP-WT and ZAP-YEEI, binding to LckSH2 was detected only for the latter, although some binding could be also observed for ZAP-WT after longer exposure of the immunoblot (not shown). This finding demonstrates that ZAP-YEEI does interact with higher efficiency with LckSH2 compared with ZAP-WT. It should be noted, however, that this result cannot be uniquely attributed to the increased affinity of binding to LckSH2 of ZAP-YEEI compared with ZAP-WT. Indeed, as shown in Fig. 5A , ZAP-YEEI has an increased tyrosine phosphorylation compared with ZAP-WT and, in principle, accumulation of phosphorylated Tyr 319 could in part account for this result. function (16) . We have proposed that the dominant negative phenotype observed for ZAP-Y319F could be explained if Tyr 319 is the binding site for a molecule involved in the positive regulation of ZAP-70 activity, such as Lck (16) . We now provide much evidence indicating that Tyr 319 of ZAP-70 is a binding site for LckSH2. First, a phosphorylated peptide encompassing Tyr 319 was able to compete for the binding of ZAP-70 to LckSH2 (Fig. 3A) . Moreover, mutation of Tyr 319 to phenylalanine impaired the binding of ZAP-70 to LckSH2 (Fig. 3C) . Finally, CNBr fragments of ZAP-70 containing phosphorylated Tyr 319 specifically bound LckSH2 (Fig. 3D ). In agreement with the notion that Lck interacts with ZAP-70 by binding to phosphorylated Tyr 319 , a ZAP-70 mutant (ZAP-YEEI) in which the Y 319 SDP sequence has been changed to the optimal binding site for the SH2 domain of Lck, YEEI, displays a gain-offunction phenotype. Indeed, when expressed in Jurkat cells, ZAP-YEEI showed an increased tyrosine phosphorylation and catalytic activity (Fig. 5) , resulting in an augmented ability to induce NFAT-dependent transcription (Fig. 4) . These data also reveal that an increase in the affinity of the SH2-mediated interaction between Lck and ZAP-70 has dramatic functional consequences on TCR signaling.
Our previous work and data from other laboratories have suggested a model in which, once associated to the ITAMs, ZAP-70 autophosphorylates on several tyrosines including Tyr 319 (6, 16) , thus generating a binding site for LckSH2. The subsequent SH2-mediated interaction between Lck and ZAP-70 would allow phosphorylation of Tyr 493 in the activation loop, thus ensuring an effective phosphorylation/activation of ZAP-70 by Lck (7, 9) . However, contribution of other PTKs (e.g. Lck) in the phosphorylation of Tyr 319 cannot be ruled out (7). The property of Src PTKs as regulators of PTKs belonging to other families is illustrated by several examples, including the focal adhesion kinase, Itk, and Btk (32) (33) (34) (35) . In particular, the mechanism we suggest for the activation of ZAP-70 by Lck closely resembles that proposed for focal adhesion kinase (32, 33) . In that system, Src (or Fyn) binds through its SH2 domain to an autophosphorylated site ( (Fig. 3D) . It has been recently demonstrated that mutation of C-terminal Tyr 597 and Tyr 598 results in a gain-offunction mutant of ZAP-70 (38), suggesting a negative role for the phosphorylation of these residues. Moreover, mutation of Tyr 474 has been shown to generate a dominant negative mutant of ZAP-70, possibly as a result of its defective interaction with the adapter protein Shc (15) . However, contrary to Tyr 319 , mutation of Tyr 474 does not affect the activation-induced kinase activity of ZAP-70. Based on the phenotype of these mutants, it seems extremely unlikely that residues Tyr 474 or Tyr 597 /Tyr 598 are involved in the binding of LckSH2. It has been reported that the tyrosines in the activation loop are the docking site for LckSH2 on Syk. We have shown that this is not the case for ZAP-70 (10). Moreover, Syk was shown to function independently of Lck, because it can rescue the signaling defect of Lck-negative JCaM1 cells (39, 40) . Thus, the SH2-mediated interaction of Lck with Syk may have a different functional significance than Lck binding to ZAP-70 (41) .
Although the pY 319 SDP sequence diverges from the optimal binding motif (pYEEI) for SH2 of Src-PTKs (19) , it should be noted that other previously identified binding sites for SrcPTKs SH2 (e.g. on platelet-derived growth factor and CSF-1 receptors; Refs. 42 and 43) were also found to differ considerably from the optimal sequence. Molecular modeling predicts that pYSDP could be accommodated within the LckSH2-binding site (Fig. 2 ) with a main chain conformation similar to that shown for a pYEEI peptide complexed to LckSH2 (25) . According to our model, proline ϩ3 of the pYSDP motif would interact with the top of the Yϩ3 binding pocket, which in the crystal structure is occupied by the isoleucine of the pYEEI peptide. Consistent with the notion that a proline residue can substitute for isoleucine in position ϩ3, a P to I mutation in the sequence Y 319 SDP of ZAP-70 generated a mutant whose expression in Jurkat cells induced NFAT at levels similar to ZAP-WT. 3 Interestingly, a similar interaction of a proline residue with the second binding pocket was previously shown for the Lck C-terminal pY 505 QPQP regulatory sequence (44) and for the homologous residue of Hck (45) in the sequence pY 527 QQQP. In the case of the pYSDP peptide, our model suggests that the backbone would fit with an extended conformation on the surface of the LckSH2 and that the aspartate ϩ2 side chain would be in a favorable position for interacting with the arginine R␤DЈ1 (44) of the LckSH2, providing further stabilization of the complex.
We show that a pYEEI containing peptide binds LckSH2 with higher affinity than a pYSDP peptide (Fig. 3A) . Moreover, conversion of the motif Y 319 SDP into Y 319 EEI results in a ZAP-70 mutant having increased kinase activity and tyrosine phosphorylation when expressed in Jurkat cells (Fig. 5, A and  B) . Consistently, this mutant displays a gain-of-function phenotype (Fig. 4) , in agreement with the hypothesis that an increased affinity of the SH2-mediated interaction between Lck and ZAP-70 favors phosphorylation/activation of the latter. Indeed, we observed that when expressed in Jurkat cells, ZAP-YEEI bound to LckSH2 with higher efficiency compared with ZAP-WT (Fig. 7) . A higher binding affinity of LckSH2 to ZAP-70 may also result in increased Lck activity, by stabilizing an "open" (active) conformation of the enzyme and/or favoring the recruitment of Lck in the proximity of specific substrates other than ZAP-70. We cannot exclude the possibility that this mechanism contributes in part to the enhanced NFAT activity induced by ZAP-YEEI.
Because ZAP-YEEI binds to phosphorylated ITAMs with affinity comparable with that of ZAP-WT (Fig. 6 ) and because the mutation does not increase the basal catalytic activity of the PTK (Fig. 5B) , we can exclude the possibility that the effects of Y 319 SDP to Y 319 EEI mutation are due to a structural alteration of the molecule, confirming that the most likely explanation for the phenotype observed for ZAP-YEEI is its increased affinity for LckSH2. Moreover, ZAP-YEEI displays its gain-of-function phenotype only in cells expressing a functional TCR (Fig. 4C) , suggesting that the molecule is not constitutively active and needs to be recruited to the plasma membrane to interact with Lck and activate the signaling pathways usually stimulated by ZAP-70.
The phenotype of ZAP-YEEI suggests that the SH2-mediated Lck-ZAP-70 interaction is critical for setting the threshold of TCR-induced responses. Indeed, an interaction with a suboptimal affinity between ZAP-70 and Lck, mediated by LckSH2 binding to Y 319 SDP motif, may be better suited for keeping T-cell activation under tight control. Our results also point at the SH2-mediated interaction of Lck to ZAP-70 as a new and highly specific pharmacological target for the manipulation of T-cell responses.
